Product Information
LEVOCARNITINE 1 G/10 ML SOLN is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1450 per ML under NDC 64980050312. Its NADAC has been published 666 times since Nov 28, 2013.
FDA first approved this application on Aug 10, 2004. Its Orange Book therapeutic-equivalence code is AA.
Strength
1 g/10mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980050312
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOCARNITINEApproval Type
Generic (ANDA)
FDA Application
ANDA076851FDA Approved
8/10/2004
TE Code
AA
On Market Since
9/20/2004
Pharmacological Classes
Price Statistics
The NADAC for LEVOCARNITINE 1 G/10 ML SOLN has been published 666 times since Nov 28, 2013, and over the history we have for it it has declined 11.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1450 per ML |
|---|---|
| All-time high | $0.8905 (Dec 14, 2016) |
| All-time low | $0.1106 (Jul 17, 2024) |
| 52-week high | $0.1502 |
| 52-week low | $0.1329 |
| Median price | $0.1965 |
| Average price | $0.2320 |
| Largest weekly change | +196.3% (Oct 19, 2016) |
| Weeks tracked | 666 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levocarnitine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Carnitine Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOCARNITINE 1 G/10 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCARNITINE 1 G/10 ML SOLN, manufactured by Rising Pharma Holdings Inc., is $0.1450 per ML (NDC 64980050312), effective Sep 30, 2026.
How has the price of LEVOCARNITINE 1 G/10 ML SOLN changed over time?
Over the history we have for it, the NADAC for LEVOCARNITINE 1 G/10 ML SOLN has declined 11.0%. It has been tracked across 666 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVOCARNITINE 1 G/10 ML SOLN?
Since Nov 28, 2013, the NADAC for LEVOCARNITINE 1 G/10 ML SOLN has ranged from a low of $0.1106 (Jul 17, 2024) to a high of $0.8905 (Dec 14, 2016), with a median of $0.1965 per ML.
Are there cheaper alternatives to LEVOCARNITINE 1 G/10 ML SOLN?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOCARNITINE 1 G/10 ML SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVOCARNITINE 1 G/10 ML SOLN?
LEVOCARNITINE 1 G/10 ML SOLN (NDC 64980050312) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.